Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lux

Showing results (181-190 of 233) with videos related to

Pageof 24
Sort By:
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 1 - Prevention and Early StagesElmar Stickeler, Bahriye Aktas, Annika Behrens, et al.
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and BiomarkersNina Ditsch, Elmar Stickeler, Annika Behrens, et al.
Breast Cancer Research and Treatment|June 11, 2016
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patientsAlexander Hein, Paul Gass, Christina Barbara Walter, et al.
BMC Cancer|November 12, 2020
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in GermanyHanna Huebner, Christian M Kurbacher, Geoffrey Kuesters, et al.
Geburtshilfe Und Frauenheilkunde|July 29, 2022
Update Breast Cancer 2022 Part 1 - Early Stage Breast CancerManfred Welslau, Volkmar Müller, Diana Lüftner, et al.
ACS Synthetic Biology|November 22, 2019
Organism Engineering for the Bioproduction of the Triaminotrinitrobenzene (TATB) Precursor Phloroglucinol (PG)Adam Meyer, Ishtiaq Saaem, Adam Silverman, et al.
Geburtshilfe Und Frauenheilkunde|June 17, 2024
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast CancerRachel Würstlein, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registryVolkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.
Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:
Pageof 24
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 1 - Prevention and Early StagesElmar Stickeler, Bahriye Aktas, Annika Behrens, et al.
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and BiomarkersNina Ditsch, Elmar Stickeler, Annika Behrens, et al.
Breast Cancer Research and Treatment|June 11, 2016
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patientsAlexander Hein, Paul Gass, Christina Barbara Walter, et al.
BMC Cancer|November 12, 2020
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in GermanyHanna Huebner, Christian M Kurbacher, Geoffrey Kuesters, et al.
Geburtshilfe Und Frauenheilkunde|July 29, 2022
Update Breast Cancer 2022 Part 1 - Early Stage Breast CancerManfred Welslau, Volkmar Müller, Diana Lüftner, et al.
ACS Synthetic Biology|November 22, 2019
Organism Engineering for the Bioproduction of the Triaminotrinitrobenzene (TATB) Precursor Phloroglucinol (PG)Adam Meyer, Ishtiaq Saaem, Adam Silverman, et al.
Geburtshilfe Und Frauenheilkunde|June 17, 2024
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast CancerRachel Würstlein, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registryVolkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.
Pageof 24